Literature DB >> 29391980

Reliability of Frozen Section Pathology in Transoral Laser Laryngectomy.

Emre Ocak1, Süha Beton1, Günay Abbasova1, Ayça Karabork2, Mustafa Kürşat Gökcan1.   

Abstract

OBJECTIVE: To evaluate the reliability of frozen section analysis in transoral laser laryngectomy (TOLL).
METHODS: A retrospective analysis was conducted for patients who underwent TOLL in a university hospital between January 2012 and February 2014. The grade of the tumor and the histopathological diagnosis were noted. The results of frozen section pathologies and routine histological examinations were compared.
RESULTS: A total number of 84 sections from 21 patients with a mean age of 57.3 years were included in the study. All the patients were operated with superpulse continuous mode carbon dioxide laser with a power of 5-8 watts. Squamous cell carcinoma was histologically diagnosed in all patients. The tumor was grade 1 in 80.95% of the patients, grade 2 in 9.52%, and grade 3 in 9.52%. A routine histopathological examination confirmed the frozen section in 94.04% of the patients.
CONCLUSION: Laser surgery is a commonly preferred treatment modality in early-stage laryngeal carcinomas, in particular. However, a safe surgical margin is a debate in transoral laser surgery. In light of our results, we can conclude that frozen section pathology is a reliable method to achieve safe surgical margins in TOLL.

Entities:  

Keywords:  Frozen section; laser laryngectomy; reliability; transoral surgery

Year:  2015        PMID: 29391980      PMCID: PMC5783000          DOI: 10.5152/tao.2015.1023

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  12 in total

1.  Margin photocoagulation in laser surgery for early glottic cancer: impact on disease local control.

Authors:  Marco Lucioni; Andy Bertolin; Luca D'Ascanio; Giuseppe Rizzotto
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-04       Impact factor: 3.497

2.  Paediatric granular cell tumour of the larynx: case report of laser resection with frozen section.

Authors:  C Holton; H E Cruickshank; A S High; K Maclennan; Z G G Makura
Journal:  J Laryngol Otol       Date:  2007-01-25       Impact factor: 1.469

3.  Impact of use of frozen section assessment of operative margins on survival in oral cancer.

Authors:  Kumar Alok Pathak; Richard W Nason; Carla Penner; Norbert R Viallet; Donna Sutherland; Paul D Kerr
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-12-13

4.  Is frozen section reliable in transoral CO(2) laser-assisted cordectomies?

Authors:  Marc Remacle; Nayla Matar; Monique Delos; Marie-Cecile Nollevaux; Jacques Jamart; Georges Lawson
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-09-27       Impact factor: 2.503

5.  Accuracy of frozen section diagnosis: a retrospective analysis of 4785 cases.

Authors:  Charlotte Winther; Niels Graem
Journal:  APMIS       Date:  2011-02-24       Impact factor: 3.205

6.  Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser.

Authors:  M S Strong; G J Jako
Journal:  Ann Otol Rhinol Laryngol       Date:  1972-12       Impact factor: 1.547

7.  Accuracy of frozen sections in assessing margins in oral cancer resection.

Authors:  R A Ord; S Aisner
Journal:  J Oral Maxillofac Surg       Date:  1997-07       Impact factor: 1.895

8.  History of the carbon dioxide laser in otolaryngologic surgery.

Authors:  G T Simpson; T G Polanyi
Journal:  Otolaryngol Clin North Am       Date:  1983-11       Impact factor: 3.346

9.  Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery.

Authors:  L J DiNardo; J Lin; L S Karageorge; C N Powers
Journal:  Laryngoscope       Date:  2000-10       Impact factor: 3.325

10.  Interinstitutional comparison of frozen section consultation in small hospitals: a College of American Pathologists Q-Probes study of 18,532 frozen section consultation diagnoses in 233 small hospitals.

Authors:  D A Novis; G N Gephardt; R J Zarbo
Journal:  Arch Pathol Lab Med       Date:  1996-12       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.